Craneware Regulatory News (CRW)

12 November 2019

Craneware plc

("Craneware" or the "Company")

AGM Statement

Appointment of Chairman

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, will hold its Annual General Meet today at 10am. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:

We have made good progress in the first four months of the year, continuing to sign the contracts that were delayed from the second half of the previous year and progressing towards the successful conclusion of the remainder. Our Value Cycle strategy and the Trisus platform continue to resonate within the C-suite of US hospitals allowing us to deepen our relationship with our customers. Our sales pipeline continues to grow with opportunities across hospitals of all sizes, for our core Chargemaster Toolkit and Pharmacy ChargeLink products, as well as our new cloud-based Trisus solutions. Results are in line with management expectations and we look forward to providing a greater level of detail within our Interim Results.

Appointment of Chairman

As announced in our Final Results in September, our long-standing Chairman George Elliott has decided to step down from his position on the Board of Craneware. George has been a fantastic support to me, the Board and the business as a whole. Joining us just prior to our IPO, he has overseen tremendous growth in the company during his tenure and will be missed by us all. He hands on the baton for the next leg of our journey, as we aim to make the Trisus platform ubiquitous in hospitals throughout the United States. We wish him all the very best for the future and personally from me "tight-lines".

George will be succeeded in the role of Chairman by Will Whitehorn, who will join us as Chairman of the Board from 1 January 2020. We are delighted to have secured an individual of his calibre. Will joined Virgin in 1986 where he established a career as Sir Richard Branson's corporate affairs advisor and brand development director for the group globally. He helped develop Virgin Atlantic, Virgin Trains and Virgin Media as businesses and went onto become the first President of Virgin Galactic taking the business from a dream to reality. He is currently Chairman of Good Energy Group plc and Deputy Chairman of Stagecoach Group plc, as well as previously being a non-executive director of both Purplebricks Group plc and GVC Holdings plc.

Commenting on his appointment, Will Whitehorn said, "I am delighted to be joining Craneware. It has a fantastic platform for growth which continues to have great prospects to develop new opportunities in its core US markets and is led by a strong team, who I am very much looking forward to working with over the coming years."

Outlook

The ongoing transition to value-based care is a powerful underlying driver for our software. We are committed to providing our customers with the tools they require to continue to deliver outstanding care to their communities and are passionate about the central role we will play in this substantial evolution of the US healthcare market. We remain focused on the delivery of our growing opportunity and confident we have the correct strategy to succeed.

Director Appointment Information

Directorships of William Elliott Whitehorn, aged 59

There are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

 For further information, please contact:

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.